ArticleCancers2023

Is There a Role for Molecular Testing for Low-Risk Differentiated Thyroid Cancer? A Cost-Effectiveness Analysis.

Idit Tessler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.